Neurocysticercosis: challenges in pediatric neurosurgery practice

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
CHILDS NERVOUS SYSTEM, v.39, n.3, p.743-750, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
PurposeNeurocysticercosis (NCC) is considered a neglected infectious disease, but the most common parasitic disease of the central nervous system (CNS). Due to oral tendencies in childhood, it is hypothesized that individuals are infected around this age and develop symptoms as lately as during young adulthood. Although it is considered a benign disease, it may cause great impact in the patient's quality of life due to epilepsy, visual symptoms, and hydrocephalus, which eventually requires frequent hospitalizations. The treatment of hydrocephalus is the main challenge for neurosurgeons.MethodsWe performed a concise review on neurocysticercosis in children and the main presentations of NCC in the neurosurgery practice and a systematic review on hydrocephalus secondary to extraparenchymal NCC.ResultsOur review showed a rate of complete resolution of hydrocephalus secondary to NCC of around 80% with the first attempt of surgical treatment combined with medication therapy. Endoscopic removal of the intraventricular cysts with third ventriculostomy was the most common treatment modality. Patients previously managed with ventricular shunts are likely to have worse outcomes and complications.ConclusionEndoscopic approach is the gold standard surgical treatment for hydrocephalus secondary to neurocysticercosis.
Palavras-chave
Neurocysticercosis, Hydrocephalus, Ventriculostomy
Referências
  1. Agapejev S, 2003, ARQ NEURO-PSIQUIAT, V61, P822, DOI 10.1590/S0004-282X2003000500022
  2. Aggarwal Varun Kumar, 2020, Asian J Neurosurg, V15, P527, DOI 10.4103/ajns.AJNS_112_20
  3. Anandh B, 2001, MINIM INVAS NEUROSUR, V44, P194, DOI 10.1055/s-2001-19928
  4. Bazan R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005115
  5. Biswas Rakhi, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P249, DOI 10.1590/S0036-46652004000500003
  6. Colli B O, 1994, Arq Neuropsiquiatr, V52, P166
  7. Coyle CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001500
  8. de Oliveira RS, 2018, CHILD NERV SYST, V34, P1957, DOI 10.1007/s00381-018-3889-4
  9. Del Brutto OH, 2020, EXPERT REV ANTI-INFE, V18, P789, DOI 10.1080/14787210.2020.1761332
  10. Garcia HH, 2014, LANCET NEUROL, V13, P1202, DOI 10.1016/S1474-4422(14)70094-8
  11. Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002
  12. Goel RK, 2008, J CLIN NEUROSCI, V15, P1096, DOI 10.1016/j.jocn.2007.10.004
  13. Husain M, 2007, ACTA NEUROCHIR, V149, P341, DOI 10.1007/s00701-006-1059-z
  14. Kaif M, 2019, TURK NEUROSURG, V29, P59, DOI 10.5137/1019-5149.JTN.21389-17.3
  15. Konar S, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106179
  16. Li ZY, 2017, WORLD NEUROSURG, V107, P853, DOI 10.1016/j.wneu.2017.08.059
  17. LOBATO RD, 1981, J NEUROSURG, V55, P786, DOI 10.3171/jns.1981.55.5.0786
  18. Martins-Melo FR, 2016, ACTA TROP, V153, P128, DOI 10.1016/j.actatropica.2015.10.011
  19. Matushita H, 2011, CHILD NERV SYST, V27, P1709, DOI 10.1007/s00381-011-1500-3
  20. Monk EJM, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000215.pub5
  21. MONTEIRO L, 1993, J NEUROL, V241, P15, DOI 10.1007/BF00870666
  22. Murrieta I, 2021, T ROY SOC TROP MED H, V115, P1218, DOI 10.1093/trstmh/traa174
  23. Nash TE, 2018, AM J TROP MED HYG, V98, P1755, DOI 10.4269/ajtmh.18-0085
  24. Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870
  25. O'Neal SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001953
  26. Psarros TG, 2004, MINIM INVAS NEUROSUR, V47, P346, DOI 10.1055/s-2004-830134
  27. Psarros TG, 2003, MINIM INVAS NEUROSUR, V46, P331, DOI 10.1055/s-2003-812470
  28. Raina Sunil Kumar, 2012, Epilepsy Res Treat, V2012, P802747, DOI 10.1155/2012/802747
  29. Rajshekhar V, 2004, NEUROLOGY, V62, P2236, DOI 10.1212/01.WNL.0000130471.19171.D8
  30. Rajshekhar V, 2001, NEUROLOGY, V57, P2315, DOI 10.1212/WNL.57.12.2315
  31. Ruiz-Garcia M, 1997, CHILD NERV SYST, V13, P608, DOI 10.1007/s003810050152
  32. Serpa JA, 2012, PATHOG GLOB HEALTH, V106, P256, DOI 10.1179/2047773212Y.0000000028
  33. Sharma BS, 2019, WORLD NEUROSURG, V122, pE647, DOI 10.1016/j.wneu.2018.10.117
  34. Singh G, 2013, EPILEPSIA, V54, P783, DOI 10.1111/epi.12159
  35. Singh S, 2019, WORLD NEUROSURG, V125, pE74, DOI 10.1016/j.wneu.2018.12.191
  36. Spallone A, 2020, J PATHOG, V2020, DOI 10.1155/2020/8174240
  37. Torres-Corzo JG, 2010, CLIN NEUROL NEUROSUR, V112, P11, DOI 10.1016/j.clineuro.2009.08.022
  38. White AC, 2018, CURR OPIN INFECT DIS, V31, P377, DOI 10.1097/QCO.0000000000000480